Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition episode artwork

EPISODE · Apr 15, 2024 · 37 MIN

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

from Oncology Today with Dr Neil Love

Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Apr 15, 2024

Embed this episode

Ready to play

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

0:00 37:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Today with Dr Neil Love?

This episode is 37 minutes long.

When was this Oncology Today with Dr Neil Love episode published?

This episode was published on April 15, 2024.

Can I download this Oncology Today with Dr Neil Love episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!